Tag: rare

3billion is accelerating the global expansion of its ZEBRA AI genetic variant interpretation platform by improving reliability, accessibility and clinical adoption across domestic and international medical and research institutions.

SK Plasma launches 'Revolpak' for treating thrombocytopenia, expanding its portfolio in rare and severe blood disorders.

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

3billion launches the Family Insight Test, a genomic diagnostic tool for high-risk families, enhancing genetic risk assessment and family planning.

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Three Billion, an AI-based rare disease diagnostic company, collaborates with Seoul National University Hospital on a major genomic study.